Assertio Therapeutics Stock Performance
| ASRT Stock | USD 11.81 0.45 3.67% |
On a scale of 0 to 100, Assertio Therapeutics holds a performance score of 4. The firm shows a Beta (market volatility) of 1.16, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Assertio Therapeutics will likely underperform. Please check Assertio Therapeutics' value at risk, as well as the relationship between the kurtosis and price action indicator , to make a quick decision on whether Assertio Therapeutics' price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Assertio Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Assertio Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.24 | Five Day Return 5.33 | Year To Date Return 34.14 | Ten Year Return (98.65) | All Time Return (94.55) |
Last Split Factor 1:15 | Last Split Date 2025-12-26 |
1 | Assertio Holdings Non-GAAP EPS of 0.18, revenue of 49.46M beats by 22.44M | 11/10/2025 |
2 | Assertio Holdings, Inc. Q3 2025 Earnings Call Transcript | 11/11/2025 |
3 | Acquisition by Mark Reisenauer of 500000 shares of Assertio Therapeutics subject to Rule 16b-3 | 11/13/2025 |
4 | Assertio Holdings announces resignation of Brendan OGrady from board By Investing.com - Investing.com India | 11/21/2025 |
5 | Assertio Trading Down 3.2 percent - Time to Sell - MarketBeat | 12/15/2025 |
6 | Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split | 12/22/2025 |
7 | What momentum indicators show for Assertio Holdings Inc. stock - July 2025 Intraday Action Trade Opportunity Analysis Reports - ulpravda.ru | 01/08/2026 |
8 | Is Assertio Stock Outpacing Its Medical Peers This Year | 01/14/2026 |
9 | Wall Street Analysts Think Assertio Could Surge 249.87 percent Read This Before Placing a Bet | 01/16/2026 |
| Begin Period Cash Flow | 73.4 M | |
| Total Cashflows From Investing Activities | -48.9 M |
Assertio Therapeutics Relative Risk vs. Return Landscape
If you would invest 1,128 in Assertio Therapeutics on October 30, 2025 and sell it today you would earn a total of 98.00 from holding Assertio Therapeutics or generate 8.69% return on investment over 90 days. Assertio Therapeutics is currently generating 0.2124% in daily expected returns and assumes 3.9144% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Assertio, and 96% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Assertio Therapeutics Target Price Odds to finish over Current Price
The tendency of Assertio Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 11.81 | 90 days | 11.81 | about 23.58 |
Based on a normal probability distribution, the odds of Assertio Therapeutics to move above the current price in 90 days from now is about 23.58 (This Assertio Therapeutics probability density function shows the probability of Assertio Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.16 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Assertio Therapeutics will likely underperform. Additionally Assertio Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Assertio Therapeutics Price Density |
| Price |
Predictive Modules for Assertio Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Assertio Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Assertio Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Assertio Therapeutics is not an exception. The market had few large corrections towards the Assertio Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Assertio Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Assertio Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.0073 | |
β | Beta against Dow Jones | 1.16 | |
σ | Overall volatility | 1.00 | |
Ir | Information ratio | 0 |
Assertio Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Assertio Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Assertio Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Assertio Therapeutics had very high historical volatility over the last 90 days | |
| Assertio Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 124.96 M. Net Loss for the year was (21.58 M) with profit before overhead, payroll, taxes, and interest of 89.93 M. | |
| Latest headline from finance.yahoo.com: Wall Street Analysts Think Assertio Could Surge 249.87 percent Read This Before Placing a Bet |
Assertio Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Assertio Stock often depends not only on the future outlook of the current and potential Assertio Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Assertio Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.4 M | |
| Cash And Short Term Investments | 100.1 M |
Assertio Therapeutics Fundamentals Growth
Assertio Stock prices reflect investors' perceptions of the future prospects and financial health of Assertio Therapeutics, and Assertio Therapeutics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Assertio Stock performance.
| Return On Equity | -0.24 | ||||
| Return On Asset | -0.0417 | ||||
| Profit Margin | (0.21) % | ||||
| Operating Margin | 0.29 % | ||||
| Current Valuation | 25.17 M | ||||
| Shares Outstanding | 6.42 M | ||||
| Price To Earning | 4.93 X | ||||
| Price To Book | 0.74 X | ||||
| Price To Sales | 0.57 X | ||||
| Revenue | 124.96 M | ||||
| Gross Profit | 89.93 M | ||||
| EBITDA | 5.15 M | ||||
| Net Income | (21.58 M) | ||||
| Cash And Equivalents | 52.26 M | ||||
| Cash Per Share | 1.09 X | ||||
| Total Debt | 40.27 M | ||||
| Debt To Equity | 0.49 % | ||||
| Current Ratio | 1.00 X | ||||
| Book Value Per Share | 16.49 X | ||||
| Cash Flow From Operations | 26.41 M | ||||
| Earnings Per Share | (4.50) X | ||||
| Market Capitalization | 78.67 M | ||||
| Total Asset | 284.73 M | ||||
| Retained Earnings | (673.12 M) | ||||
| Working Capital | 87.86 M | ||||
| Current Asset | 5.15 M | ||||
| Current Liabilities | 492.4 K | ||||
About Assertio Therapeutics Performance
Assessing Assertio Therapeutics' fundamental ratios provides investors with valuable insights into Assertio Therapeutics' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Assertio Therapeutics is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 409.92 | 322.76 | |
| Return On Tangible Assets | (0.10) | (0.10) | |
| Return On Capital Employed | (0.13) | (0.14) | |
| Return On Assets | (0.07) | (0.07) | |
| Return On Equity | (0.20) | (0.19) |
Things to note about Assertio Therapeutics performance evaluation
Checking the ongoing alerts about Assertio Therapeutics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Assertio Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Assertio Therapeutics had very high historical volatility over the last 90 days | |
| Assertio Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 124.96 M. Net Loss for the year was (21.58 M) with profit before overhead, payroll, taxes, and interest of 89.93 M. | |
| Latest headline from finance.yahoo.com: Wall Street Analysts Think Assertio Could Surge 249.87 percent Read This Before Placing a Bet |
- Analyzing Assertio Therapeutics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Assertio Therapeutics' stock is overvalued or undervalued compared to its peers.
- Examining Assertio Therapeutics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Assertio Therapeutics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Assertio Therapeutics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Assertio Therapeutics' stock. These opinions can provide insight into Assertio Therapeutics' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Assertio Stock Analysis
When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.